Pharmstandard company is the leader of the domestic pharmaceutical industry. According to the Pharmexpert Center for Information Research at the end of 2008, Pharmstandard took first position in the retail segment of the market and second position among all pharmaceutical companies, being the only domestic company among the top ten leaders in the pharmaceutical market in Russia.

The Pharmstandard company produces more than 200 items medicines for the treatment of cardiovascular diseases, diabetes mellitus, growth hormone deficiency, gastroenterological, neurological, infectious diseases, metabolic disorders, cancer and other diseases. Of these, 90 drugs are included in the “List of Essential Medicines” (VED).

Pharmstandard has agreements with Grindeks, Latvia, for the exclusive distribution and promotion of the drug Mildronate, as well as with Solvay Pharmaceuticals, France, for the production of IRS 19 and Imudon.

In the period from 2004-2009. More than 39 new drugs have been developed and introduced. Priority areas of development are genetic engineering, vitamin and mineral, cardiological and gastroenterological drugs. The company actively cooperates with the country's leading scientific institutions to develop new high-tech medicines.

The company includes 4 pharmaceutical Russian factories, with a total production capacity of 1.3 billion packages per year. Six production lines of Pharmstandard-Leksredstva PJSC received certificates of compliance with international EU GMP standards. PJSC "Pharmstandard - Leksredstva" - the first Russian enterprise, included in the European EudraGMP (European Medicines Agency, EMEA) database. All production capacity companies fully meet the requirements Russian standards.

In addition to its pharmaceutical business, Pharmstandard produces and sells high-tech medical equipment, as well as disposable medical products.

Pharmstandard has invested more than 3 billion rubles in the modernization and development of its enterprises since the beginning of 2004.

Since 2005, Pharmstandard has included PJSC Tyumen Plant of Medical Equipment and Instruments (TZMOI), the leader in the domestic market of medical equipment and disposable products.

TZMOI was founded in April 1962, and has been developing, designing and manufacturing medical steam sterilizers for almost 50 years. Product line includes models with chamber volumes from 10 to 2250 dm3. Along with simple models sterilizers with semi-automatic control, equipment is produced with automatic microprocessor control, fore-vacuum, devices for documenting and recording sterilization parameters, the ability computer diagnostics, as well as universal type sterilizers (for processing medical products, textile materials and medicinal solutions). In addition to sterilizers, the group of medical equipment includes water distillers, water storage tanks, disinfection boilers, as well as spare parts.

Since 1989, TZMOI was one of the first enterprises in Russia to establish mass production of single-use injection syringes. This product group includes special syringes for insulin and tuberculin with a capacity of 1 ml, as well as two-piece syringes with a capacity of 2 (2.5) to 20 ml. In addition to syringes, the group of disposable products includes injection needles, catheters, probes, urinals, and Esmarch cup tips.

The TZMOI quality management system is certified for compliance International standards ISO quality 9001:2000, ISO 13485:2003. Syringes and needles have an EU certificate, which allows these products to be marked with the “CE” mark.

About Working at Pharmstandard, also known as OTC-pharm.

1. There is no personnel policy as such:
1) They invite and hire people in most cases for those positions in which they do not want and cannot work in the current team. Basically, either difficult areas or positions in advance with the prospect of dismissing a person after a certain period of time.
2) It is not scoundrels and sycophants who are attacked by colleagues. Much more often talented and bright people fall under the fire of corporate hatred, then people with a soft character and, conversely, too straightforward “fighters for justice.” http://nsk.erabota.ru/blogs/articles/5442/

3) This approach further formulates the company’s violation of the law: in terms of the Labor Code of the Russian Federation and the Arbitration Procedure Code of the Russian Federation. In some cases, violations occur on the part of company employees in terms of the Criminal Code of the Russian Federation.

Real situation:
Girl employee of the company. Her immediate supervisor regularly calls her into her office and makes her faint with her attacks. Everyone is aware of this incident. They try to hush it up, the person is urgently sent home in a faint state. The next day the person is admitted to the hospital for an indefinite period. After three months, the person is simply forced to resign from the Pharmastandrt company. I must say that the girl has 2 young children.

IF desired this moment is a fact of the proceedings for the Prosecutor's Office and the court.

2. The qualifications of employees are very often covered by their loyalty and lack of initiative.
1) Example: In the financial department, which was once managed by:
Russkikh Elena, Russkikh Natalya, Arkhangelskaya Elena.
For a very long time they made a report in which net profit was increased by Income Tax. Well, other similar serious mistakes.
At the same time, when you show them their mistakes, they begin to get angry and react inadequately to their own incompetence.

2) Employees eagerly spend a lot of time on behind-the-scenes games instead of core functionality. Therefore, there is no question of any company efficiency with this approach.

3. Social responsibility the company and its management.
They do not hesitate to rummage through the personal belongings of their work colleagues. Once, returning from lunch, I was surprised by the fact that my personal belongings - my bag - were being searched by my colleague, Dmitry Yuryevich Makarov. At the same time, there are cameras all around, everything is viewed and recorded. This is an article of the Criminal Code of the Russian Federation.

The company itself denies the fact of the reductions. In 2013, family employees were the first to be laid off. Employees with children.

4. Being in a leading industry, the company spends virtually no money on research, preferring to vacuum the market by buying up developments from the Soviet period.

To summarize I can say:
- the core of the company is satisfied with the current income and they do not see the point in working.
- many people go to work to play psychological games, instead of the basis of the work. Up to interference in the personal life of an employee.
- The company team strongly supports the current situation.
- massive violations of the law.
- reduction in income payments on flimsy pretexts.
- outdated product line.
- use of a semi-monopoly position in the market, instead of real work.

The holding is huge and heterogeneous, depending on your luck. For some, luck is to kick the cannon, for others it is to develop and work in a good team. There are departments for both the former and the latter. In the "fields" it is also different. Don’t judge by HR, they’re weird here)

Eat great amount characters with self-importance on a universal scale and negative efficiency. And the budget for their maintenance is a type of charity in favor of mentally disabled people.

07.11.19 18:14 MoscowWorker,

Office near the metro.

The analyst vacancy is updated from time to time and is constantly posted. At the interview, it is positioned that analysts have been working here for a long time. The head of the department states this very pathetically. A stupid attentiveness test for third graders. Lack of feedback.

01.10.19 13:48 in the Moscow regionCoca Cola,

good voluntary health insurance, if you don’t take into account dentistry, where you can only do ultrasonic teeth cleaning once a year, white salary on a VTB or Sberbank card, that’s all

gossip and cronyism. If you came through an advertisement, you can’t even dream of any career growth. I’ll tell you separately about the position of “Project Administrator” with comrade I.B. Zyryanov. If you value yourself even a little, run away from here, I'm serious. At the interview, everyone talks colorfully about how wonderful the IT team is (a lie, everyone follows each other and knocks on Zyryanova so that...

21.03.19 11:48 MoscowLelya Krok,

Not a bad office

This was the first place I was asked when I was going to have my third child. And I had a lot of interviews. I was tempted to ask if they ask similar questions to men. Additionally, they have 3 or 4 rounds of interviews. At the same time, the vacancy has been hanging for more than six months. They talked down to me (mostly the head of the department, HR nothing yet). They tortured me for a long time about my life path...

26.10.18 22:15MoscowBuyer,

26.10.18 22:13MoscowBuyer,

Feedback from the buyer. Medicines - most of fake. Mukaltin, what the hell, it won’t do anyone any good, and it won’t do any harm either. The tablets contain pure soda. It doesn’t even smell like Mucaltin, which we use to treat coughs. They just sell pressed soda. Advice: do not buy medications from this company! This is a dummy!

13.09.18 15:43 in the Moscow regionFormer employee

Stable company, salary is not delayed, there are bonuses, VHI is normal, especially for leadership positions, corporate events, canteen, sometimes they can even send you to study courses (rarely). An excellent opportunity for growth - if, of course, you did not come from the street, but a relative or friend of someone from the management. Director at Pharmstandard LLC Darko Y. is smart, knowledgeable and decent, it’s a pity that there are two deputies for them,...

If you are an ordinary employee, there is little good, especially in the purchasing department of an LLC, there are two deputies Mashnikov and Strigulin, who treat everyone below them as cattle who have no right to their own opinion, and with any mistake they will be smeared, absolutely authoritarian communication style. If you are a decent person and a professional, it will be difficult for you here, because... You have to show a lot of loyalty...

05.02.18 16:21 MoscowMasha Anastasia,

I worked for more than six months. Leadership: Podgorbunskikh N.I., Usmanova E. and Count Tolstov - completely inadequate. They don’t know what they want from their employees, they are rude and bring them to tears. They hired me for one position, but the responsibilities turned out to be completely different. Sneaky surveillance of people, a work report every day about your every step (when you went to the toilet, ate, surfed the Internet) Low and disgusting, and this, for a minute...



Assignees:


Legal predecessors:


Activities:

Main (according to OKVED code ed.2): 46.46.1 - Wholesale trade of pharmaceutical products

Additional activities according to OKVED 2:

accounting, including preparation of accounting (financial) statements, accounting consulting; - activities related to auditing the accounting (financial) statements of organizations and providing audit-related services, carried out by audit organizations and individual auditors; - tax consulting and representation of clients before tax authorities, including preparation of tax documentation This group does not include: - processing and generation of summary data, see 63.11; - management consulting related to accounting systems, budget management procedures, see 70.22; - collection of payments on bills, see 82.91"> passenger cars with driver and light vans with driver, see 49.32, 49.39"> intellectual property and similar products in which a royalty or license fee is paid to the owner of the product (asset holder). Renting these products can take various forms, such as permission to reproduce, use in downstream processes or in the production of products, running a business as a franchise, etc. n. Owners may or may not be the authors of these products. This group includes: - rental of intellectual property products (except for works protected by copyright, for example, books or software); - receipt of royalties or license fees for the use of: patented objects, trademarks or service marks, brand names, licenses for exploration, production and evaluation of mineral raw materials, franchises This group does not include: - acquisition of rights to publications, see 58 and 59; - creation, reproduction and distribution of works protected by copyright (books, software, films), see 58, 59; - rental of real estate, see 68.20; - rental of tangible property, see 77.1, 77.2, 77.3">
21.20.1 Production of medicinal products
26.60.1 Production of devices used for medical purposes based on the use of X-ray, alpha, beta and gamma radiation
46.18.1 Activities of agents specializing in wholesale trade pharmaceuticals, medical products, perfumes and cosmetics, including soaps, and cleaning products
47.73 Retail trade of medicines in specialized stores (pharmacies)
52.10 Warehousing and storage activities
62.02 Advisory activities and work in the field of computer technology
68.20.2 Rent and management of own or leased non-residential real estate
69.20 Activities to provide services in the field of accounting, financial audit, tax consulting
72.20 Research and development in social sciences and humanities
77.11 Rental and leasing of cars and light vehicles
77.33 Renting and leasing of office machines and equipment, including computer equipment
77.39 Renting and leasing of other types of transport, equipment and materials not included in other groups
77.40 Rent of intellectual property and similar products, except copyrights
86.21 General practice

Founders:


She is or was in the past a founder of the following organizations:

dateNameTINShareSum
30.12.2019 JSC "KIROV PLASMA"7709994605 30 million rub.
23.12.2019 LLC "GLOBALCHIMPHARM"5024155443 100% 10 thousand rub.
23.12.2019 LLC "PHARM COMPANY"5024192847 100% 500 thousand rub.
06.12.2019 LLC "MIG"9729102215 82.89% 8.289 thousand rub.
31.10.2019 LLC "MIG DIGITAL"9703004090 100% 100 thousand rub.
12.07.2019 LLC "MASTERPLASMA"3321023968 52% 52 thousand rub.
31.05.2019 FARMARTIS INTERNATIONAL LLC7726546233 50.001% 5.0001 thousand rub.
31.05.2019 OOO "MIRAMEDIX"7707431004 20.38% 20.38 thousand rub.
06.05.2019 LLC "SELLTERA PHARM"3321033317 75% 750 thousand rub.

Registration with the Pension Fund Russian Federation:

Registration number: 060006007494

Registration date: 15.08.2007

Name of the PFR body: State institution - Main Directorate of the Pension Fund of the Russian Federation No. 5 Directorate No. 6 of Dolgoprudny, Moscow Region

URG entry into the Unified State Register of Legal Entities: 2075047151848

27.08.2007

Registration with the Social Insurance Fund of the Russian Federation:

Registration number: 027400801050261

Registration date: 27.09.2007

Name of the FSS body: Branch No. 26 Government institution- Moscow regional branch of the Social Insurance Fund of the Russian Federation

URG entry into the Unified State Register of Legal Entities: 2075047173485

Date of entry in the Unified State Register of Legal Entities: 12.10.2007


According to rkn.gov.ru dated January 31, 2020, according to the TIN, the company is in the register of operators processing personal data:

Registration number:

Date of entry of the operator into the register: 06.11.2018

Grounds for entering the operator into the register (order number): 245

Operator location address: 141700, Moscow region, Dolgoprudny, Likhachevsky proezd, 5B

Start date of personal data processing: 05.05.2006

Subjects of the Russian Federation on whose territory personal data is processed: Moscow, Moscow region

Purpose of processing personal data: compliance and fulfillment of the requirements of labor, tax and labor protection legislation of the Russian Federation, ensuring the maintenance personnel work, accounting and tax accounting, remuneration and bonuses for employees, training and advanced training of employees, provision of compensation and benefits to employees and relatives of employees, including voluntary insurance, accident insurance, provision of vouchers to children's camps, gifts for children of employees, provision of workers company cars as part of the performance of their labor functions, organizing trips and business trips, organizing employee training, forming a personnel reserve and selecting candidates for vacant positions, ensuring internal order, safety and security of property, ensuring access control, identifying conflicts of interest, carrying out marketing activities and promoting products on the market, including carrying out newsletters and business contacts with healthcare professionals, compliance and fulfillment of the requirements of the legislation of the Russian Federation and other regulatory legal acts in the field of healthcare and the circulation of medicines, providing reliable information about products and new drugs, monitoring product safety, ensuring interaction with counterparties and fulfilling obligations under concluded contracts, carrying out activities within the framework of due diligence when choosing contractors, creating publicly available sources of personal data , including directories, address books, internal corporate resources, compliance and implementation of the requirements of the legislation of the Russian Federation and other regulatory legal acts in the field of personal data protection.

Description of the measures provided for in Art. 18.1 and 19 of the Law: Local acts have been developed and approved on the issues of processing and ensuring the protection of personal data, as well as local acts establishing procedures aimed at preventing and identifying violations of legislation in the field of personal data protection. A person responsible for the processing of personal data has been appointed. Implemented internal control compliance of the processing of personal data with this Federal Law and the regulatory legal acts adopted in accordance with it, requirements for the protection of personal data, an annual audit of compliance with the requirements of current legislation is provided. Employees directly involved in the processing of personal data are familiar with the provisions of the legislation of the Russian Federation on personal data, including the requirements for the protection of personal data, documents defining the organization’s policy regarding the processing of personal data, local regulations on the processing and protection of personal data. A document defining the policy regarding the processing of personal data, including information on the implemented requirements for the protection of personal data, has been published and posted on the organization’s website. Accounting of computer storage media of personal data is ensured in accordance with the requirements of current legislation as part of the inventory of technical equipment. We use protective equipment that has undergone the compliance procedure in accordance with the established procedure. It is ensured that facts of unauthorized access to personal data are detected and appropriate measures are taken. The restoration of personal data modified or destroyed due to unauthorized access to it is ensured. A system for access to personal data processed in the personal data information system has been developed, and registration and accounting of all actions performed with personal data in the personal data information system are ensured. Personal data is available to a strictly defined circle of employees, the building is equipped with security and fire alarms, physical security of the information system (hardware and storage media), providing for control of access to the information system premises of unauthorized persons, the presence of reliable obstacles to unauthorized entry into the information system premises and storage media storage. Access to server rooms is limited by access control means (access control). Access to the company premises by unauthorized persons is only possible if accompanied by inviting employees. The safety of server equipment used in the processing of personal data is ensured by restricting access to the premises in which the server equipment is located. The safety of personal data media is ensured through access control measures and access control to the relevant media.

Categories of personal data: biometric personal data, surname, first name, patronymic, year of birth, month of birth, date of birth, place of birth, address, marital status, social status, property status, education, profession, income, health status, citizenship, registration address and actual residence, details of an identity document (series, number, date of issue, name of the authority that issued the document), information on a foreign passport, information on military registration (military rank, date of issue of a military ID card, fitness category, reserve category and profile, name of the commissariat that issued military ID, relation to military duty, series and number of the military ID), information about education, qualifications and the presence of special knowledge or special training (series, number, date of issue of the diploma, certificate, certificate or other document of completion educational institution, name of the educational institution, date of start and completion of training, faculty or department, qualification and specialty upon graduation from the educational institution, academic degree, academic title, possession foreign languages), age, sick leave information, amount of temporary disability benefits, bank account information necessary for calculating and paying salaries, information on the amount of salary, information on bonuses paid, information on bonuses, taxes, deductions, information on residence / non-residence, position, information about labor activity, information about employers, career advancement, disciplinary sanctions, transitions to new position/ place of work, reasons for dismissal, data on the investigation and recording of industrial accidents and occupational diseases, in accordance with the legislation of the Russian Federation, which are not medical secrets and related to the issue of the possibility of fulfillment labor function, information about social benefits and social status(series, number, date of issue, name of the body that issued the document that is the basis for the provision of benefits and status, and other information), information about awards (incentives), honorary titles, details of the document confirming the right to receive benefits/material assistance, SNILS , TIN, information about pension contributions, driver’s license details, category, driving experience, car make, car model, car VIN, state. number, accident data, contact phone number, address Email, information about visa, work permit and legal status, country of residence, medical policy data (Compulsory Medical Insurance/VHI/NS), data from a document confirming the occurrence of an insured event, data about an adverse event, information about the time of entry and exit of visitors from the company’s territory.

Categories of subjects whose personal data is processed: Belonging to employees of Pharmstandard JSC, dismissed employees, relatives of employees, candidates for vacant positions, employees of counterparties as part of the fulfillment of obligations under concluded contracts, executors under civil contracts, specialists involved in the healthcare system of the Russian Federation, including those owned medical workers(including doctors of various specialties), representatives and administrators medical institutions, pharmacies, consumers of pharmaceutical products, visitors to the company’s office, employees of the company’s affiliates.

List of actions with personal data: By: collection, recording, systematization, accumulation, storage, clarification (updating, changing), extraction, use, transfer (distribution, provision, access), deletion, destruction of personal data, blocking of personal data

Processing of personal data: mixed, with transmission over the internal network legal entity, with transmission over the Internet

Legal basis for processing personal data: Guided by the Constitution of the Russian Federation, the Civil Code of the Russian Federation, Labor Code RF, Tax Code of the Russian Federation, Civil Procedure Code of the Russian Federation, Arbitration Procedural Code of the Russian Federation, Criminal Code of the Russian Federation, Criminal Procedure Code of the Russian Federation, Code of the Russian Federation on administrative offenses, Federal law dated 04/06/2011 No. 63-FZ “On electronic signature", Federal Law of December 26, 1995 No. 208-FZ "On joint stock companies", Federal Law of April 22, 1996 No. 39-FZ "On the Market valuable papers", Regulations on the disclosure of information by issuers of issue-grade securities, approved by order of the Federal Financial Markets Service of Russia dated October 4, 2011 N 11-46/pz-n, Requirements for the protection of personal data when processed in information systems personal data approved by Decree of the Government of the Russian Federation dated November 1, 2012 No. 1119, Regulations on the peculiarities of processing personal data carried out without the use of automation tools, approved by Decree of the Government of the Russian Federation dated September 15, 2008 No. 687, Law of the Russian Federation dated April 19, 1991 No. 1032-1 “On employment of the population in the Russian Federation", Federal Law dated 04/01/1996 No. 27-FZ "On individual (personalized) accounting in the compulsory pension insurance system", Federal Law dated 07/24/1998 No. 125-FZ "On compulsory social insurance against accidents in production and occupational diseases", Federal Law of July 24, 2009. No. 212-FZ “On insurance premiums in Pension Fund Russian Federation, Social Insurance Fund of the Russian Federation, Federal Compulsory Medical Insurance Fund", Federal Law dated December 6, 2011 No. 402-FZ “On Accounting”, Federal Law dated November 21, 2011 No. 323-FZ “On the Fundamentals of Protecting the Health of Citizens”, Federal Law of April 12, 2010 No. 61-FZ “On the Circulation of Medicines”, Federal Law of August 23, 1996 No. 127-FZ “On Science and State Scientific and Technical Policy”, Order of the Ministry of Health of Russia dated April 1, 2016 No. 200N “On Approval rules of good clinical practice", Letter of Roszdravnadzor dated July 15, 2009 N 01I-396/09 "On the Guidelines for Good Practice in the Production of Medicines", Federal Law dated February 7, 1992 No. 2300-1 "On the Protection of Consumer Rights", Federal Law dated October 22 .2004 No. 125-FZ “On archiving in the Russian Federation”, the requirements of GOST R 52379-2005 “Good clinical practice”, Order of the Ministry of Health of the Russian Federation dated 04/01/2016 No. 200n “On approval of the rules of good clinical practice”, Letter Roszdravnadzor dated July 15, 2009 No. 01I-396/09 “On the Guidelines for Good Practices in the Production of Medicines”, with the requirements of GOST R 52249-2009 “ National standard production and quality control of medicinal products (GMP)" (approved by Order of Rostekhregulirovanie dated May 20, 2009 N 159-st), contracts, agreements on the terms of assignment of personal data processing, as well as the Charter of Pharmstandard JSC.

Availability of cross-border transmission: Yes

Database location information: Russia


Information on income and expenses according to the Federal Tax Service dated 10/19/2019 using TIN 0274110679:

YearIncomeExpensesIncome - Expenses
2018 101 620 000 000 rub. 53 939 300 000 rub. 47 680 700 000 rub.

Information on the paid amounts of taxes and fees according to the Federal Tax Service dated 10/19/2019 using TIN 0274110679:

YearNameSum
2018 Debt and recalculations for CANCELED TAXES and fees and other obligatory payments (except for Unified Social Tax, insurance contributions)0 rub.
2018 NON-TAX INCOME administered by tax authorities0 rub.
2018 Transport tax4 962 080 rub.
2018 Insurance premiums for mandatory social insurance in case of temporary disability and in connection with maternity2 040 640 rub.
2018 Value added tax1 669 530 000 rub.
2018 Insurance and other contributions for compulsory pension insurance credited to the Pension Fund of the Russian Federation333 957 000 rub.
2018 Insurance premiums for compulsory health insurance of the working population, credited to the budget of the Federal Compulsory Health Insurance Fund110 072 000 rub.
2018 Organizational property tax280 331 rub.
2018 Income tax2 544 280 000 rub.

Financial reports (accounting indicators):
CodeIndexMeaningUnit.
F1.1110Intangible assets41066 thousand rub.
F1.1120Research and development results17420 thousand rub.
F1.1130Intangible search assets0 thousand rub.
F1.1140Material prospecting assets0 thousand rub.
F1.1150Fixed assets376039 thousand rub.
F1.1160Profitable investments in material assets0 thousand rub.
F1.1170Financial investments8687740 thousand rub.
F1.1180Deferred tax assets1493220 thousand rub.
F1.1190Other noncurrent assets160204 thousand rub.
F1.1100Total for section I - Non-current assets 10775700 thousand rub.
F1.1210Reserves6517500 thousand rub.
F1.1220Value added tax on purchased assets3449 thousand rub.
F1.1230Accounts receivable60862300 thousand rub.
F1.1240Financial investments (excluding cash equivalents)26642700 thousand rub.
F1.1250Cash and cash equivalents14905800 thousand rub.
F1.1260Other current assets0 thousand rub.
F1.1200Total for section II - Current assets 108932000 thousand rub.
F1.1600BALANCE (asset) 119708000 thousand rub.
F1.1310Authorized capital (share capital, authorized capital, contributions of partners)37793 thousand rub.
F1.1320Own shares purchased from shareholders0 thousand rub.
F1.1340Revaluation of non-current assets0 thousand rub.
F1.1350Additional capital (without revaluation)0 thousand rub.
F1.1360Reserve capital1890 thousand rub.
F1.1370Retained earnings (uncovered loss)9294990 thousand rub.
F1.1300Total by section III- Capital and reserves 9334670 thousand rub.
F1.1410Borrowed funds35312500 thousand rub.
F1.1420Deferred tax liabilities71863 thousand rub.
F1.1430Estimated liabilities0 thousand rub.
F1.1450Other obligations0 thousand rub.
F1.1400Total for Section IV - Long-term liabilities 35384400 thousand rub.
F1.1510Borrowed funds3375000 thousand rub.
F1.1520Accounts payable71335200 thousand rub.
F1.1530revenue of the future periods846 thousand rub.
F1.1540Estimated liabilities277418 thousand rub.
F1.1550Other obligations0 thousand rub.
F1.1500Total for section V - Current liabilities 74988500 thousand rub.
F1.1700BALANCE (passive) 119708000 thousand rub.
F2.2110Revenue57223300 thousand rub.
F2.2120Cost of sales42684700 thousand rub.
F2.2100Gross profit (loss) 14538700 thousand rub.
F2.2210Business expenses2518280 thousand rub.
F2.2220Administrative expenses2030020 thousand rub.
F2.2200Profit (loss) from sales 9990380 thousand rub.
F2.2310Income from participation in other organizations36900000 thousand rub.
F2.2320Interest receivable1845650 thousand rub.
F2.2330Percentage to be paid1437080 thousand rub.
F2.2340Other income5651380 thousand rub.
F2.2350other expenses5269290 thousand rub.
F2.2300Profit (loss) before tax 47681000 thousand rub.
F2.2410Current income tax2816910 thousand rub.
F2.2421incl. permanent tax liabilities (assets)-4536 thousand rub.
F2.2430Change in deferred tax liabilities-39023 thousand rub.
F2.2450Change in deferred tax assets707388 thousand rub.
F2.2460Other-19946 thousand rub.
F2.2400Net income (loss) 45512500 thousand rub.
F2.2510Result from the revaluation of non-current assets, not included in the net profit (loss) of the period0 thousand rub.
F2.2520Result from other operations not included in the net profit (loss) of the period0 thousand rub.
F2.2500Total financial results period 45512500 thousand rub.
F3.3600Net assets9335520 thousand rub.

Pharmstandard OJSC is a leading pharmaceutical company in Russia, engaged in the development and production of modern, high-quality, affordable medicines that meet healthcare requirements and patient expectations.

The Company's best-known drugs today are Arbidol®, Complivit®, Pentalgin®, Flucostat®, Phosphogliv®, Amiksin®, Afobazol®, Rastan® and Biosulin®. The Pharmstandard group of companies produces more than 250 types of medicines, including drugs for the treatment of cardiovascular diseases, diabetes mellitus, growth hormone deficiency, gastroenterological, neurological, infectious diseases, metabolic disorders, cancer and other diseases. More than 120 drugs (including all forms and dosages) are included in the “List of Vital and Essential Medicines”.

Since 2004, more than 60 new drugs have been developed and introduced in collaboration with leading scientific centers Russia.

Pharmstandard OJSC is a participant in the joint biotechnological project "Generium" for the development and production of socially significant drugs within the framework of state program import substitution.

The total production capacity allows the company to produce more than 1.7 billion packages per year. The production capacity of the Pharmstandard group of companies is provided by 8 modern plants for the production of medicines: Pharmstandard-Leksredstva OJSC (Kursk), Pharmstandard-UfaVITA OJSC (Ufa), Pharmstandard-Tomskkhimpharm OJSC (Tomsk) , PJSC "Pharmstandard-Biolek" (Kharkov, Ukraine), JSC "Biomed" named after. I. I. Mechnikova (Moscow, Moscow region), PHARMAPARK LLC (Moscow), Lekko CJSC (Vladimir region, Volginsky village) and the medical equipment plant OJSC TZMOI, Tyumen. Pharmstandard LLC (Moscow), which purchases and supplies raw materials for the purpose of further production of pharmaceutical products at the production sites of factories that are part of the Pharmstandard group of companies.

All production facilities of the Company fully meet the requirements of Russian standards. 6 production lines of Pharmstandard-Leksredstva OJSC received certificates of compliance with European standards European Union Good Manufacturing Practice (European standards of good manufacturing). industrial practice). The Company's management has approved a program for the transition of factories to European GMP standards by 2014.

On May 4, 2007, Pharmstandard OJSC conducted a public offering of shares (Initial Public Offering, IPO). Shares and global depositary receipts of Pharmstandard OJSC are traded on the MICEX-RTS and LSE (London Stock Exchange) exchange platforms, respectively.